Nanopatch for Effective, Pain-Free Vaccine Delivery: Interview with David Hoey, CEO of Vaxxas

David Hoey is the CEO and director of the Vaxxas, a company working on enhancing the performance of existing and next generation vaccines through a novel vaccine delivery technology called Nanopatch. The Nanopatch approach consists of using thousands of vaccine coated microprojections that painlessly perforate into the outer layers of the skin. Th (Read more...)

Full Story →